ABSTRACT
. Although controversy about the identity of the subunit proteins of PHFs persisted for some time, the debate was resolved when sodium dodecyl sulfate-soluble PHFs were purified from AD brains and shown to consist of CNS tau proteins that were abnormally phosphorylated at specific residues (e.g., at Ser) in PHFtau but not in normal tau proteins that were isolated from the adult postmortem brain (18) (19) (20) (21) (22) (23) (24) (25) (26) Taken together, these prelimitiamy studies suggested that all of the major sites of abnormal pllospltorylation in PHFtau were Ser/Pm'o or Thr/Pro sites. However, a very recent reassessment of the sites of l)hosl)hotylatiOn in PHFtau using ion spray mass spectrometry led to the identification of 19 such sites in PHFtau, and 10 of these sites were found to be nonproline-directed (36). Because there are 17 Ser/Pro om'Thr/Pt'o sites in the largest hutimn brain tau isoform and 14 of these sites are shared by all 6 CNS tau proteins, it will be important to vem'ify the identity of those proline-directed and nonproline-directed sites that in(leed are aberrantly phosphotylated in PUFtau relative to normal fetal and adult human CNS tau.
By 1992, the accepted view that absolute differemices existed between the sites of phosphorylation in PHFtaLt vs. normal human CNS tau began to erode when additional studies showed that the pimosphorylation state of PHFtau partially recapitulated the phosphorylation state of fetal human amid rat CNS tau (16, 19, 22, 37, 38) . For example, Set202 amid Set3 were shown to be phosphot'ylated in PHFtau and in the smallest tau isofot'm isolated from postmortem samples of the fetal human CNS, but not in any of the sixtau isoformiis (imicittding so-called fetaltau)isolatedl from postniortem samples of the normal adult CNS (19, 22) . However, more tecetit studiessuggestthatas many as 11 phosphotylatiomi sitesin PHFtau are shared by fetal human CNS tan atid PHFtau (36). Although fetal hutnan CNS tau was shown to be phosphotylated at Set202and Set396, like PHFtau, fetalhumati tau was capable of binding to MTs (albeit less well thami adult CNS tau proteins), amidPHFtau completely lostthe ability to bind MIs (19) . This loss of function was reversible because dephosphorylationof PHE'tau restotedthe abilityof PHFtau to bind MTs (19) . Taken together, these studies suggest that the accumulatiomi of nettrofibtillamy lesiotis iii AD could he due totime aberrantreactivation of "fetal" proteinkinasesand/ot the inactivatioti of fetal protein phosphatases imi the AD bm-aitt.Tile absence of any AD lesionsin the fetalCNS (16, 39-41) further suggested thatthese putativefetalkitiases and phosphatases were able to tegimlate tile phosphorylatiott state of fetal tau without leading totime generatioti amid accumulation of derivatizedforms of tan equivalent to the abtiot'malPHFtau found in the AD brain. Accordingly, based omistudiesthatwere pulilisimeci by the end Of 1993, PHFtau not only appeared to he an aberrantlyphospliomylated form of normal adult humiian CNS tau, but italso seemed plausiblethat PHFtau partially recapitulatedthe phosphorylation stateof normal fetalhuman CNS tau. However, even the modified view of PHFtau that emerged from the studiesdescribed al)overequired 1-eassessment aftersubsequent studiesof rapidlyisolatedCNS tan proteinsobtained from human corticalbrain biopsies and ft'omfresh samples of nomihuman primate and rodetit bt-ains (42) (43) (44) (45) . For examiiple, irnpottatit new data obtained ft'omthe studiesof human brain biopsy-derivedCNS tau suggested thatfreshlyisolatedadult human CNS tau (i.e., tan pI'oteins isolatedwith little or no interval between tissue excision and analysis) am-c phospliorylated at almost all of the same sites as PHFtau, albeit to a fatlesser extemit thatiPHFtau (44). Notably, at least one phosphate-dependent monoclonal anti-PHFtau antibody (i.e., AT100 or AT1O) appeared to recognize PHFtau alone, but none of the normal human CNS tau proteinsftom postmortem adult and fetal ot biopsy-derivedadultbrainsamples (44). Thus, at least one phosphate acceptor site (i.e., the phosphotylation site contained withiti the tau epitope recognized by the AT100 monoclonal antibody) seems to be abnormally pimosphorylated in PHFtau relativeto normal humami CNS tau.Among other timings, these data suggest that some of the previously noted differencesin the phosphorylation stateof normal adult CNS tau vs. PHFtau obtained from studiesof postmortem brain samples may reflect the mote rapid dephosphorylation of normal tau vs. PHFtau during similar postmortem intervals. Indeed, experimental studies of the effects of varying intervals between the time of removal of a brain biopsy or a rodent brain and the isolation of tau provided evidence implying that CNS protein phosphatases remained active in these brain samples and that these phosphatases rapidly dephosphorylated normal CNS tau proteins to an extent similar to that seen in tau proteins isolated from tiormalantopsy-(ierived braitis afterposttnorternintervals of 6 iior more (44, 45) .
ROLE OF PHOSPHATASES IN THE

PATHOGENESIS OF PAIRED HELICAL FILAMENT TAU
Whethet' or not the apparent hyperphosphotylation of PHFtau vs.normal CNS tau iti time postmortem brain isdue to the reduced levelsor activity of specificphosphatase conipomientsin the AD braitiremains to be deteimined. However, recetitstudies (44) suggest that both protein phosphatase 2A (PP2A) and 2B (PP2B) activities wet-c pt-esent in the human brain biopsy samples and timat PP2A and PP2B (also known as calcineut'in)were able to dephosphotylateliutnami CNS tau imi a site-specific manner. For example, Scm396t-eqnired 0.1 M okadaic acidi forcomplete imiliibitioti of dephosphorylation by phosphatase ent-ichedbiopsy-derivedbrain exttacts, atidtimeremoval of divalentions was ineffective iti blocking dephosplmoryla-
Further,because trifluozepan, ealyculimi A, amidcantharidinblocked dephosphot'ylation of tau at Set3, and protein phosphatase 1 was shown to be incapable of dephosphorylatingtan (46) ,these data may he interpt-eted to suggest that PP2A and PP2B were involved in the dephosphorylationof tan at Set396 In conti-ast, cantharidin and calyculin A, but not tt'iflttozepan, wet-c capable of blocking the dephosphorylationof tau at Ser202, suggesting timat PP2A alomie may regulatethe dephosphorylationof tau at thissite. Thus, these data may imply that a downt-eguiatiomi or inactivation ofpliosphataseactivities (including PP2A and PP2B) occurs iii the humnan brain dut-ing time pi-ogi-ession of AD and that timis could he responsible for the accumulation of the abnormally phosphorylated PHFtau proteinsas PHFs in NFTs and dystt-ophic neurites in the AD brain.
Although the studiesdescribed above serve to focus attemition on the possibility that phosphatases may play a major role in the conversiotiof normal CNS tau into PHFtau, the ititerpretation of these studiesis limitedbecause of the paucity of information oti time nortnal biology of braimi protein phosphatases.
Further, time potential i-ole that l)rainphospliatasesniay play in the pathogenesis of PHFtau and tteurofibrillaty lesionsin the AD brain isotily beginning to be deciphet-ed. Fot example, inadditiontothe studiesdescribed above, othet preliminaryevidence that has emerged in the last3 yeats suggeststhatproteinphosphatase 2A1 (PP2A1) and PP2B ot'calcineurin may be implicated in the conversion of nonnal tau into PHFtau (43, (46) (47) (48) (49) (50) .
Nonetheless, given the complexity of the biology of Ser/Thi' proteinphosphatases and theit' regitlatomy subutiits in ciiffet-ent tissuesamidcelltypes,as well as the t-elatively scant amount of imiformation about the ptoteili pliosphatasesin the CNS (51),itisclear that mLtch niot'e needs to be learned about these enzymes in the imom-timal human brain in orderto utiderstandtheiri-ole in the pathogenesisof AD. Finally,recent studies suggest that the protein tyrosine kinasefyn may regulatethe activity of candidate prolinedirectedkinases involvedin the abnormal phosphorylation of CNS tau and thatfyn thus may be involvedin abnormal phosphorylationcascades in the AD braimi (66) .
Although the data from studiesof biopsy-derivedhuman CNS tau proteins (44) in the generation of PHFtau before it is possible to fully undei'stand the role of neurofibrillary pathology in the premature atid excessivelossof neurons in AD as well as in the dementia thatisso characteristic ofthisdisorder. Finally, othercomponents associatedwith PHFs or tangle-bearingneurons (e.g., apolipoproteinE isoforms,aluminum) may serve as cofactors in the abnormal piiosphorylationof PHFtau and/or in the accumulation of PHFs in neurons of the AD brain (3, (67) (68) (69) , making itnecessary todelineatethe role of these putative cofactorsin the pathogenesisof PHFtau.
BIOLOGICAL AND PATHOLOGICAL CONSEQUENCES OF PAIRED HELICAL FILAMENT TAU IN ALZHEIMER'S DISEASE
Although current undem'standing of time pathohiologyof AD isstill fragmentary,timeinformationavailablefi-om studies of neurof'mbrillaty lesiomms in AD suggests that the cotiversion of normal tau into PHFtau might have cleletetious effects on neuromisduring the progressioti ofAD. Fom-example,time accumulation of PHFtau in the AD cot-tex appears to correlate closely with the abundance of NETs as well as with diminished levels of normal MT bindimig ('ompetemmt tau iti the CNS (19, 20) . Furthem', because abnormal or excessively phosphorylated PHFtau appears to be unable to bimid to MTs (19, 38) , it is plausible to infer that time conversion of normal tau into PHFtau could lower the levels of MT bitiding tau, destabilize MIs, disrupt axonal tiansport, and lead to the "dyimig back" of axons in AD ( Fig.   1 ; 5, [18] [19] [20] 70 (70, 71) . Althouglm the mechanistic scenario set forth above and iii Fig. 1 must be viewed as hypothetical at this time, it is entirely consistent with curretmtly available itmfom'mation on the regulation of tubulimi assembly, the futictions of MIs, time role of tau proteins iti pt-omotitmg the assembly and stability of MTs, and ihe biology of PHFtau (2, 5. 14, 72, 73) . However, the lack of a mmeuronal culture system ol' aimimal model timat fully recai)ittmlales the formnatiomi of ADlike PliFtan. cOupie(l with time progressive accumulation of imitt-atieutonal neurofihm'illaiy lesions such as timose seemi in AD, is a (iattntitmg impediment to effotts directed at testing time imypothelical scenario outlined above (74, 75) . Timis iimmmitationmiotwithstammdimmg, compelling support for the notioim thmat time accumulation of PHFtau in tieut-ofibrillaty lesiomis may ummdethietime dysfumictioti and degetieratiomi of mieuromms imi AD commies frotmi recent biochemical atmd mieuropatiiological studies of the Gttamatiiamm Cimamorro population with ALS/PDC. These studies imave demotmstrated tlmat the NFTs iti Guatmm ALS-PDC contaimi PHFs, amid timat timese PilFs ate structurally atid immunologically sitnilar, if not idetitical, to the PHFs atmd PHFtau proteimms seetm immthe NFl's of classical AD patiemits (13, 76). TIme itivariai)le abundammce of NFl's atmd the relative paucity or absemmce of atnyloid-rich SP5, otiier deposits of A13, as well as the absence of accumnulations of LBs in time braimms of these Chamortos, strongly suggest that NETs are directly involved imm the dysfttnctiomm amid dlegemmematiomm of mmeuromms in these patients regardless of time clinical phenotype of timeir disease. Thus, data from studies of Guammm ALS-PDC set-ye to directly inmplicate PIIF-tatt and tamigle formatiomi as potetitial mnediators of human mmeurodegermerative diseases chat'acterized by abun(hamit NFl's sucim as classical AD. Finally, time notiomi timat accumnulations of PHFs cottid phiysicahly "block" axotial transport in AD is supported by the recemil tlermionstmaliommof defective axonal tramisi)ort itt a transgemmic mouse model of motor tieum'omm disease that was generated by the overexpm'ession of neni-ofilamnent proteins and the accumulation of mmeurofilamermt aggmegates in affecteci spimmal cord tmeurons (77) .
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